-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 2Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases - 1 year(s) ago
Background and Objectives To evaluate the effects of the coronavirus disease 2019 (COVID-19) pandemic on the life of patients with neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody–associated diseases (MOGAD). Methods This multicenter, cross-sectional study included data of 187 patients recruited from 19 different German and Austrian Neuromyelitis…
Categories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
A woman presented at age 18 years with partial myelitis and diplopia and experienced multiple subsequent relapses. Her MRI demonstrated T2 abnormalities characteristic of multiple sclerosis (MS) (white matter ovoid lesions and Dawson fingers), and CSF demonstrated an elevated IgG index and oligoclonal bands restricted to the CSF. Diagnosed with clinically definite relapsing-remitting MS, she was…
Categories: Latest Headlines, NeurologyTweet
-
Mashup Score: 12Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging - 1 year(s) ago
Background and Objectives Relapsing-remitting multiple sclerosis (RRMS), aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) may have overlapping clinical features. There is an unmet need for imaging markers that differentiate between them when serologic testing is unavailable or ambiguous….
Source: NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 6Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination - 1 year(s) ago
Background and Objectives Acute inflammatory CNS diseases include neuromyelitis optica spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD). Both MOGAD and acute disseminated encephalomyelitis (ADEM) have been reported after vaccination. Consequently, the mass SARS-CoV-2 vaccination program could result in increased rates of these conditions. We…
Categories: Latest Headlines, NeurologyTweet
-
Mashup Score: 3Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar - 1 year(s) ago
Background and Objectives Satralizumab, an interleukin 6 receptor inhibitor, reduced the risk of protocol-defined relapse (PDR) vs placebo in 2 independent, double-blind studies in patients with neuromyelitis optica spectrum disorder (NMOSD). We assessed the long-term efficacy of satralizumab in patients with aquaporin-4-immunoglobulin G (IgG)–seropositive (AQP4-IgG+) NMOSD. Methods Following…
Categories: Latest Headlines, NeurologyTweet
-
Mashup Score: 6Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination - 1 year(s) ago
Background and Objectives Acute inflammatory CNS diseases include neuromyelitis optica spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD). Both MOGAD and acute disseminated encephalomyelitis (ADEM) have been reported after vaccination. Consequently, the mass SARS-CoV-2 vaccination program could result in increased rates of these conditions. We…
Categories: Latest Headlines, NeurologyTweet
-
Mashup Score: 2Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease - 1 year(s) ago
Background and Objectives Rituximab is used widely for relapse prevention in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG–associated disease (MOGAD); however, data regarding the effectiveness and safety of long-term rituximab use in these conditions are limited. In this study, we sought to evaluate long-term clinical outcomes in patients with…
Source: NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment - 2 year(s) ago
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein antibody-associated disease, and neuromyelitis optica spectrum disorder. Early clinical recognition of optic neuritis is important in determining the potential aetiology, which has bearing on prognosis and treatment….
Source: The Lancet NeurologyCategories: Latest Headlines, NeurologyTweet-
In the second Review in the Series, Jeffrey Bennett and colleagues discuss advances in diagnosis and treatment of optic neuritis and autoimmune optic neuropathies, and suggest the optic nerve should be included in the McDonald criteria #MS #MOGAD #NMOSD https://t.co/wWKbNFQqaB https://t.co/WqY0iTiLIZ
-
-
Mashup Score: 3
Neurology: Neuroimmunology & Neuroinflammation Online ISSN: 2332-7812 © 2022 American Academy of Neurology
Source: nn.neurology.orgCategories: Latest Headlines, NeurologyTweet-
The Neurology: Neuroimmunology & Neuroinflammation #COVID-19 Hub is a curated collection of our COVID-19 articles. Read articles by select disease states and topics, such as multiple sclerosis, #NMOSD, vaccines, and more. Visit the site now: https://t.co/suvl0JV1Xx #NeuroTwitter https://t.co/7GTg93spR5
-
Via @ANA_journals: A new inhibitor for #NeuromyelitisOptica spectrum disorder requires less frequent dosing but appears to be as effective as current therapies: https://t.co/pJ0STH5Ld2 #neurotwitter #NMOSD #Ravulizumab @AANMember @MayoClinicNeuro https://t.co/wIx4C2hM6l